Dr. Tuli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10740 Palm River Rd
Ste 360
Tampa, FL 33619Phone+1 813-844-7585Fax+1 813-844-5882
Education & Training
- Johns Hopkins UniversityResidency, Radiation Oncology, 2007 - 2011
- Abington Memorial HospitalInternship, Internal Medicine, 2006 - 2007
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2006
Certifications & Licensure
- FL State Medical License 2020 - 2027
- NJ State Medical License 2019 - 2021
- CA State Medical License 2011 - 2020
- NY State Medical License 2019 - 2020
- PA State Medical License 2006 - 2007
- American Board of Radiology Radiation Oncology
Clinical Trials
- Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
- Veliparib in Combination With Gemcitabine and Intensity Modulated Radiation Therapy in Patients With Pancreatic Cancer Start of enrollment: 2013 Oct 02
- Improving Pancreas Radiotherapy Plans Using Respiration-driven Anatomic Deformation: A Pilot Study Start of enrollment: 2013 Jan 01
Publications & Presentations
PubMed
- 2 citationsNRG Oncology International Consensus Contouring Atlas on Target Volumes and Dosing Strategies for Dose-Escalated Pancreatic Cancer Radiation Therapy.Nina N Sanford, Amol K Narang, Todd A Aguilera, Michael F Bassetti, Michael D Chuong
International Journal of Radiation Oncology, Biology, Physics. 2025-03-15 - 44 citationsDigital twins for health: a scoping review.Evangelia Katsoulakis, Qi Wang, Huanmei Wu, Leili Shahriyari, Richard Fletcher
NPJ Digital Medicine. 2024-03-22 - 3 citationsA Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer.Paul B Romesser, Jaume Capdevila, Rocio Garcia-Carbonero, Tony Philip, Carlos Fernandez Martos
Clinical Cancer Research. 2024-02-16
Press Mentions
- Nationally Recognized Leader in Neuroendocrine and Endocrine Tumors Joins the TGH Cancer InstituteFebruary 12th, 2025
- In the War on Cancer, Tampa General Hospital Cancer Institute Employs AI in Its Newly Established Center for Precision RadiosurgeryJanuary 25th, 2024
- Tampa General and Moffitt Cancer Center Are Bringing Proton Therapy to the RegionMarch 24th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: